Shares of Allstate Corp (NYSE:ALL) have been assigned an average recommendation of “Hold” from the sixteen brokerages that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $96.00.

Several equities analysts recently commented on the company. Wells Fargo & Co restated a “buy” rating and set a $105.00 target price on shares of Allstate in a research report on Thursday, November 2nd. Zacks Investment Research upgraded Allstate from a “hold” rating to a “buy” rating and set a $115.00 price objective for the company in a research report on Tuesday, December 12th. B. Riley reiterated a “neutral” rating on shares of Allstate in a research report on Monday, November 6th. Credit Suisse Group lifted their price objective on Allstate from $91.00 to $95.00 and gave the company a “neutral” rating in a research report on Thursday, November 2nd. Finally, Goldman Sachs Group began coverage on Allstate in a research report on Monday, December 4th. They issued a “neutral” rating and a $104.00 price objective for the company.

In other news, Chairman Thomas J. Wilson sold 195,000 shares of Allstate stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $99.13, for a total value of $19,330,350.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Susan L. Lees sold 4,000 shares of Allstate stock in a transaction on Monday, November 20th. The shares were sold at an average price of $100.49, for a total value of $401,960.00. Following the completion of the sale, the executive vice president now directly owns 24,341 shares of the company’s stock, valued at $2,446,027.09. The disclosure for this sale can be found here. Insiders sold a total of 432,242 shares of company stock valued at $42,827,931 over the last three months. Insiders own 1.58% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Canada Pension Plan Investment Board grew its stake in shares of Allstate by 3.1% during the third quarter. Canada Pension Plan Investment Board now owns 491,833 shares of the insurance provider’s stock worth $45,204,000 after purchasing an additional 14,700 shares during the period. Aperio Group LLC grew its stake in shares of Allstate by 16.4% during the third quarter. Aperio Group LLC now owns 410,026 shares of the insurance provider’s stock worth $37,685,000 after purchasing an additional 57,713 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its stake in shares of Allstate by 2.0% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 85,160 shares of the insurance provider’s stock worth $7,860,000 after purchasing an additional 1,700 shares during the period. Toronto Dominion Bank grew its stake in shares of Allstate by 11.1% during the third quarter. Toronto Dominion Bank now owns 137,390 shares of the insurance provider’s stock worth $12,627,000 after purchasing an additional 13,713 shares during the period. Finally, BT Investment Management Ltd grew its stake in shares of Allstate by 2.5% during the third quarter. BT Investment Management Ltd now owns 215,126 shares of the insurance provider’s stock worth $19,800,000 after purchasing an additional 5,268 shares during the period. 76.56% of the stock is owned by institutional investors and hedge funds.

Allstate (NYSE:ALL) traded down $0.30 during trading on Tuesday, hitting $103.70. The company had a trading volume of 1,548,986 shares, compared to its average volume of 2,199,077. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.26 and a quick ratio of 0.26. The company has a market cap of $37,210.00, a P/E ratio of 14.40, a PEG ratio of 1.55 and a beta of 1.12. Allstate has a 1-year low of $73.96 and a 1-year high of $105.36.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, November 1st. The insurance provider reported $1.60 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.61 by ($0.01). The company had revenue of $8.12 billion for the quarter, compared to the consensus estimate of $8.07 billion. Allstate had a return on equity of 13.11% and a net margin of 7.32%. Allstate’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.26 EPS. sell-side analysts anticipate that Allstate will post 6.16 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Thursday, November 30th were paid a $0.37 dividend. The ex-dividend date of this dividend was Wednesday, November 29th. This represents a $1.48 annualized dividend and a dividend yield of 1.43%. Allstate’s dividend payout ratio (DPR) is currently 20.56%.

TRADEMARK VIOLATION WARNING: “Brokerages Set Allstate Corp (ALL) Price Target at $96.00” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2018/01/19/brokerages-set-allstate-corp-all-price-target-at-96-00.html.

Allstate Company Profile

The Allstate Corporation (Allstate) is a holding company for Allstate Insurance Company. The Company’s business is conducted principally through Allstate Insurance Company, Allstate Life Insurance Company and other subsidiaries. It is engaged in the property-liability insurance business and the life insurance, retirement and investment products business.

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.